星点设计-效应面法优化双苷清咽含片处方的研究

研究芒果苷、罗汉果甜苷和薄荷脑对双苷清咽含片抗炎药效的贡献,优选出该含片的最优处方。以小鼠腹腔通透性和二甲苯致小鼠耳廓肿胀度为指标,采用星点设计-效应面优化法,研究芒果苷、罗汉果甜苷和薄荷脑的用量对双苷清咽含片抗炎药效的影响。结果表明,对抗炎药效影响的主次顺序为芒果苷 > 罗汉果甜苷 > 薄荷脑;星点设计-效应面法优化法给出的优化处方范围为芒果苷占素片片重8.50%～17.50%;罗汉果甜苷占6.37%～13.13%,薄荷脑占0.18%～0.42%;最优处方为芒果苷占素片片重13.00%,罗汉果甜苷占9.75%,薄荷脑占0.30%。应用星点设计-效应面优化法可快速准确地给出双苷清咽含片的最优处方;双苷清咽含片的抗炎药效主要取决于芒果苷和罗汉果甜苷的用量,薄荷脑的用量无显著影响。

Prescription optimization of Shuangganqingyan tablet by central composite design-response surface methodology

To study the contribution of mangiferin,mogroside and menthol to the anti-inflammatory effects of Shuangganqingyan tablet (SGQY tablet),it is preferred to prescribe the optimal formulation of this tablet.Mouse auricle tumefaction and abdominal capillary permeability were determined,and central composite design-response surface methodology (CCD-RSM) optimization tests were utilized to study the dosages of mangiferin,mogroside and menthol on the anti-inflammatory effects of SGQY tablet.The results showed that the main order of anti-inflammatory effects was mangiferin > mogroside > menthol.The optimized prescription range given by central composite design-response surface methodology method was that mangiferin accounted for 8.50% to 17.50% of the tablet weight,mogrosides accounted for 6.37%-13.13%,and menthol accounted for 0.18%-0.42%.The optimal prescription was that mogroside occupied accounted for 13.00% of the tablet weight,mogrosides accounted for 9.75%,and menthol accounted for 0.30%.The application of CCD-RSM method can quickly and accurately give the optimal prescription of SGQY tablet.The anti-inflammatory effect of SGQY tablet depends mainly on the amount of mangiferin and mogroside,the amount of menthol used has no significant effect.